Astraveus
We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies.
Astraveus has raised €27M across 2 funding rounds from 5 investors, most recently a Grant round in Oct 2023. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.astraveus.com ↗
Total raised
€27M
€26,900,000
Funding rounds
2
Investors
5
distinct backers
Active since
2023-06
latest 2023-10
Funding by year
EUR raised per yearAstraveus — funding by year — interactive chart.
Data table
| Astraveus — funding by year | |
|---|---|
| 2023 | €27M |
Signals
High confidenceRaise-next likelihood7
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-24 | Grant | €10M | French Government | View deal → |
| 2023-06-29 | Seed | €17M | AdBio partners,Bpifrance,JJDC – Johnson & Johnson's fund,M Ventures | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData